Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL20338348

Cc1ccnnc1C.N

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29131780 0.97 NOS3 (0.32)
SCHEMBL29770643 0.97
Hydrochloric Acid SCHEMBL28430002 0.94
Formamide SCHEMBL25308554 0.84 NOS3 (0.32)
SCHEMBL28909733 0.84
SCHEMBL28537378 0.82
SCHEMBL15004521 0.72
SCHEMBL3915380 0.70
SCHEMBL8338293 0.70
SCHEMBL6091759 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110691598-A Metalloenzyme inhibitor compounds 赛列尼蒂治疗(百慕大)有限公司 2020-01-14 CN claimed
CN-105793249-A Piperidine derivatives for the treatment or prevention of psychiatric and neurological disorders 武田药品工业株式会社 2016-07-20 CN claimed
CN-105452233-A Piperidine and azepane derivatives as prokineticin receptor modulators TAKEDA PHARMACEUTICALS CO 2016-03-30 CN claimed
EP-3562487-B1 METALLOENZYME INHIBITOR COMPOUNDS JI XING PHARMACEUTICALS HONG KONG LTD (HK) 2023-11-29 EP disclosed
CN-111132974-B Sulfonamide carboxamide compounds 英夫拉索姆有限公司 2023-11-21 CN disclosed
CN-110494431-B Azacyclo derivative, preparation method and medical application thereof 苏州浦合医药科技有限公司 2022-11-04 CN disclosed
US-20210322409-A1 METALLOENZYME INHIBITOR COMPOUNDS SELENITY THERAPEUTICS (BERMUDA), LTD. (BM) 2021-10-21 US disclosed
CN-113301963-A Substituted quinazolines as NLRP3 modulators for the treatment of cancer 先天肿瘤免疫公司 2021-08-24 CN disclosed
CN-113164481-A Cycloalkane-1, 3-diamine derivatives 第一三共株式会社 2021-07-23 CN disclosed
US-11040034-B2 Metalloenzyme inhibitor compounds PHASEBIO PHARMACEUTICALS, INC. (US) 2021-06-22 US disclosed
CN-111132974-A Novel sulfonamide carboxamide compounds 英夫拉索姆有限公司 2020-05-08 CN disclosed
CN-110494431-A Nitrogen heterocycles derivative, preparation method and its medical usage BEIJING YUEZHIKANGTAI BIOMEDICINES CO LTD 2019-11-22 CN disclosed
US-20190008861-A1 METALLOENZYME INHIBITOR COMPOUNDS CORXEL PHARMACEUTICALS HONG KONG LIMITED (HK) 2019-01-10 US disclosed
US-10085984-B2 Metalloenzyme inhibitor compounds VIAMET PHARMACEUTICALS (BERMUDA), LTD. (BM) 2018-10-02 US disclosed
US-20180185362-A1 METALLOENZYME INHIBITOR COMPOUNDS CORXEL PHARMACEUTICALS HONG KONG LIMITED (HK) 2018-07-05 US disclosed
CN-105793249-A Piperidine derivatives for the treatment or prevention of psychiatric and neurological disorders 武田药品工业株式会社 2016-07-20 CN disclosed
CN-105452233-A Piperidine and azepane derivatives as prokineticin receptor modulators TAKEDA PHARMACEUTICALS CO 2016-03-30 CN disclosed
CN-104903320-A Nitrogen-containing heterocylic compound or salt thereof FUJIFILM CORP 2015-09-09 CN disclosed
CN-101842359-A Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors NISSAN CHEMICAL IND LTD 2010-09-22 CN disclosed
CN-101495184-A Aryl and heteroaryl substituted tetrahydrobenzazepine  and its use to block reuptake of norepinephrine dopamine and serotonin AMR TECHNOLOGY INC (US) 2009-07-29 CN disclosed